Table 2.
Gene name | Fold change | p-value | FDR adj p-value |
---|---|---|---|
LOC645323 | -0.9 | 3 × 10-7 | 0.005 |
IL34 | -0.7 | 8 × 10-7 | 0.007 |
KCNA7 | 0.7 | 3 × 10-6 | 0.011 |
ANK1 | 0.6 | 4 × 10-5 | 0.045 |
DFNB31 | 0.5 | 5 × 10-5 | 0.050 |
ABCC6P1 | -0.9 | 6 × 10-5 | 0.054 |
TUBB2B | -0.6 | 6 × 10-5 | 0.054 |
ADAMTS19 | -0.7 | 6 × 10-5 | 0.055 |
KCNH8 | -0.6 | 1 × 10-4 | 0.064 |
SLITRK6 | -0.7 | 2 × 10-4 | 0.071 |
FAM13C | -0.5 | 2 × 10-4 | 0.073 |
KCNK17 | -0.9 | 2 × 10-4 | 0.075 |
STEAP1B | -0.6 | 2 × 10-4 | 0.076 |
RASGEF1C | -0.5 | 2 × 10-4 | 0.079 |
DKK1 | 1.2 | 3 × 10-4 | 0.085 |
PLAC9 | -0.5 | 3 × 10-4 | 0.085 |
SNORA53 | 0.6 | 3 × 10-4 | 0.085 |
NPPC | -1.3 | 4 × 10-4 | 0.092 |
DEPDC7 | -0.5 | 4 × 10-4 | 0.094 |
OLFML3 | -0.5 | 4 × 10-4 | 0.096 |
CLEC9A | -0.5 | 5 × 10-4 | 0.099 |
PDGFRL | -0.5 | 5 × 10-4 | 0.099 |
SOST | 1.3 | 5 × 10-4 | 0.099 |
Genes were required to fulfill two criteria to be considered differentially expressed, the absolute of the log2 of the ratio of expression in patients with poAF and patients without poAF (fold change) had to be more than 0.5, and the p-value for the expression difference adjusted to account for false discovery rate (FDR) was required to be less than 0.1